IP Library Granted Patent US 8,377,482
Granted Patent B2
US 8,377,482 · App. 11/574,692 · Granted Feb 19, 2013

Trace elements

Inventors: Robert N. Laurie (Die Wilgers, ZA); William A. Smith (Dublin, IE)
Assignee: Warburton Technology Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,377,482
App. No.
11/574,692
Granted
Feb 19, 2013
Kind
B2
Abstract

The invention discloses a trace element solution, which comprises at least one metal selected from the group comprising selenium, copper, zinc, manganese and chromium; and at least one component selected from the group comprising a vitamin, a vaccine, a growth stimulant, a dewormer, iron dextran, an antibiotic and a synchronization preparation. The synchronization preparation is a combination of injectable hormonal preparations, inplantable hormonal preparations, intravaginal hormonal preparation and other slow release hormonal preparation. The antibiotics include oral, injectable and implantable theurapeutic remedies. The vaccine includes antigens and a combination of antigens and adjuvents. The growth stimulants include zeranol, estradiol, testosterone, progesterone and trenbolone acetate. The dewormer includes macrocydic lactones, leramizoles, benzimidazoles and salicylanilides. The macrocydic lactones include doramectin, ivermectin, abamectin and moxidectin.

Claims (16)

1. A method of preparing an injectable trace element solution comprising manganese, selenium, and at least one metal selected from the group consisting of copper, zinc and chromium, said method comprising:

(a) preparing a MnCO 3 mixture in a container by mixing MnSO 4 and NaCO 3 and adding hot water having a temperature of at least 70 degrees Celsius to provide a MnCO 3 mixture at a temperature of at least 60 degrees Celsius;

(b1) adding to the container an EDTA solution selected from the group consisting of potassium EDTA solution and sodium EDTA solution and

(b2) subsequently adding at least one metal compound selected from the group consisting of ZnO, CuCO 3 , MnSO 4 and FeCl 3 ;

(c) adding Na 2 SeO 3 to the container to obtain the trace element solution;

(d) adjusting the pH of the trace element solution to 6.7 to 7.0; and

(e) adding at least one component selected from the group consisting of a vitamin, a growth stimulant, a dewormer, iron dextran and an antibiotic;

(f) wherein the combined concentration of said manganese, selenium, and at least one metal selected from the group consisting of copper, zinc and chromium is greater than 60 mg/ml.

2. The method of claim 1 , further comprising adding CrCl 3 .6H 2 O to the trace element solution.

3. The method of claim 2 , further comprising adding a EDTA/NaOH mixture prior to addition of the CrCl 3 .6H 2 O to the trace element solution.

4. The method of claim 1 , further comprising adjusting the pH of the trace element solution by adding at least one compound selected from the group consisting of NaOH and EDTA.

5. The method of claim 1 , further comprising diluting the trace element solution.

6. The method of claim 4 , wherein adding the at least one compound selected from the group consisting of NaOH and EDTA comprises adding the compound gradually in small quantities.

7. The method of claim 1 , further comprising cooling the trace element solution prior to addition of the Na 2 SeO 3 .

8. The method of claim 1 , wherein the growth stimulant is selected from the group consisting of zeranol, estradiol, testosterone, progesterone and trenbolone acetate.

9. The method of claim 1 , wherein the dewormer is at least one dewormer selected from the group consisting of macrocyclic lactones, benzimidazoles and salicylanilides.

Assignments (5)
SECURITY INTEREST Recorded Jun 3, 2026
From: WARBURTON TECHNOLOGY LIMITED
To: ALTER DOMUS (US), LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 074840/0269 →
RELEASE OF SECURITY INTEREST Recorded Feb 13, 2026
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (AS SUCCESSOR IN INTEREST TO U.S. BANK NATIONAL ASSOCIATION), AS ADMINISTRATIVE AGENT
To: AXIOTA U.S., INC. (F/K/A MS BIOTECH, INC.); WARBURTON TECHNOLOGY LIMITED
Reel/Frame 073791/0089 →
ASSIGNMENT AND ASSUMPTION AGREEMENT Recorded Mar 17, 2023
From: U.S. BANK NATIONAL ASSOCIATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 063115/0486 →
SECURITY INTEREST Recorded Dec 24, 2019
From: WARBURTON TECHNOLOGY LIMITED
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 051363/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2007
From: LAURIE, ROBERT N.; SMITH, WILLIAM A.
To: WARBURTON TECHNOLOGY LIMITED
Reel/Frame 019629/0336 →
Priority Claims (1)
ZA 2004/7201 · Sep 9, 2004 · national
Continuity (1)
Related Publication 20080102074A1 · May 1, 2008